SIBN
SI-BONE, Inc. (SIBN) Business Model Analysis (2026)
Overall Score
Revenue Quality
Gross margin remains strong at 79.5%, indicating solid product economics.
Revenue per share is $4.83, but profitability remains negative with net margin at -6.9%.
Profitability
Operating margin is -8.3% and EBITDA margin is -2.3%, showing the business is still not consistently profitable.
Return on equity is -8.2% and return on invested capital is -7.9%, indicating weak capital efficiency.
Cash Generation
Free cash flow remains negative, with free cash flow yield at -0.5% and free cash flow per share at -$0.10.
Operating cash flow is positive but thin relative to sales, with operating cash flow sales ratio at 1.2%.
Balance Sheet
Liquidity is very strong, with current ratio at 9.1x and quick ratio at 7.6x.
Leverage is low, with debt-to-equity at 0.04x and debt-to-assets at 2.9%.
Operating Efficiency
Asset turnover is 0.86x and fixed asset turnover is 7.46x, suggesting decent asset utilization.
Working capital remains tied up, with a cash conversion cycle of 302 days and inventory days of 320.4.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on SI-BONE, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

